EURO-FORTA (Fit for the Aged) list version 2: a clinical tool for assessing drug therapy in the older patients

Sychev D.A.: Russian Medical Academy of Continuing Professional Education

Cherniaeva M.: Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation, Moscow

Niyazov R.R.: Center for Scientific Consulting, Moscow

Sorokina A.: Pirogov Russian National Research Medical University, Moscow, Russia

Download in PDF

Summary

Polymorbidity and polypharmacy are common in the elderly patients and combined with the age-related changes in the body are associated with a higher risk of adverse drug reactions (ADRs). Numerous tools, e.g. EURO-FORTA list, have been developed to improve the quality of pharmacotherapy in the elderly. EURO-FORTA list was validated in several clinical studies and is convenient for use in real-life practice. It helps to reduce polypharmacy, to improve a number of parameters of a comprehensive geriatric assessment and to reduce the number of ADRs. In 2023, European experts presented an improved EURO-FORTA list, which contains 267 prescriptions (medicines or pharmacotherapeutic groups) used in treatment and most often prescribed to elderly patients, in accordance with 27 main indications for use.

Key words

Older patients, adverse drug reactions, EURO-FORTA, polypharmacy.